Best post-transplant drug regimen identified for patients with new kidneys

Combination of two immunosuppressive drugs led to less organ rejection, better organ health after transplant

2011-08-01

(Press-News.org) Washington, DC (July 29, 2011) — For the thousands of patients who receive kidney transplants in the United States each year, preventing organ rejection without compromising other aspects of health requires a delicate balance of medications. Immunosuppresive drugs that protect transplanted organs can also cause serious side effects, including compromising patients' immunity to infection, cancer, and other threats. Finding the best combination and dosage of drugs has often proved difficult for physicians.

A new multi-year study has now shown that using tacrolimus (TAC) and mycophenolate mofetil (MMF) in combination provided the best long-term benefits and the least amount of side effects after a kidney transplant. The results, which come from the longest randomized study to date that has analyzed transplant drugs, provide valuable guidance to physicians who care for for kidney transplant patients. The study, conducted by Giselle Guerra, MD, and colleagues at the University of Miami, appears in an upcoming issue of the Journal of the American Society Nephrology (JASN), a publication of the American Society of Nephrology.

To compare therapies, Dr. Guerra studied 150 kidney transplant recipients who received one of three common immunosuppressive treatment regimens: tacrolimus + MMF, tacrolimus + sirolimus, or cyclosporine + sirolimus. Tacrolimus and cyclosporine are in a class of drugs called calcineurin inhibitors; they can prevent early organ rejection but can be toxic to the kidneys. Sirolimus and MMF do not damage the kidneys. Patients often receive low doses of calcineurin inhibitors plus sirolimus or MMF in order to gain the most benefit without serious risk to their kidneys. All patients in the study also received another immunosuppressive drug called daclizumab shortly after transplantation, as well as steroids long term; they were followed for an average of eight years after transplantation.

Among the major findings: Survival of transplanted organs was similar in all groups of patients. Significantly fewer patients treated with tacrolimus + MMF (12%) experienced acute rejection, compared to those treated with tacrolimus + sirolimus (30%) or cyclosporine + sirolimus (28%). Patients taking tacrolimus + MMF also had better kidney function during the first 36 months. Patients taking tacrolimus + MMF or cyclosporine + sirolimus were less likely to die with a functioning transplant (12% and 4% respectively), compared to those treated with tacrolimus + sirolimus (26%). Patients who took sirolimus were more likely to develop viral infections, discontinue treatment, and need cholesterol-lowering medications, compared to patients who were not taking sirolimus.

Taken together, these results suggest that transplant patients do better over the long term with tacrolimus + MMF than with either tacrolimus + sirolimus or cyclosporine + sirolimus. "We have been able to prove that the use of low-dose tacrolimus and MMF is safe and provides excellent outcomes over time to renal transplant patients," said Dr. Guerra.

### Study co-authors include Gaetano Ciancio, MD, Jeffrey Gaynor, PhD, Alberto Zarak, Randolph Brown, Lois Hanson, DO, Junichiro Sageshima, MD, David Roth, MD, Linda Chen, MD, Warren Kupin, MD, Lissett Tueros, Phillip Ruiz, MD, PhD, Alan Livingstone, MD, and George Burke III, MD (University of Miami).

Disclosures: The authors of this manuscript have conflicts of interest to disclose as described by the Journal of the American Society of Nephrology. Astellas Pharma US, Inc. provided partial salary support (with a grant of $75,000) for the completion of this study to the Kidney and Kidney/Pancreas Transplant Program at the University of Miami. Representatives of Astellas had no direct involvement in this study, and none of the co-authors have any financial interest in Astellas.

The article, entitled "Randomized Trial of Immunosuppressive Regimens in Renal Transplantation," will appear online at http://jasn.asnjournals.org/ 10.1681/ASN.2011010006

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 12,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

ELSE PRESS RELEASES FROM THIS DATE:

Grapes protect against ultraviolet radiation

2011-08-01

Some compounds found in grapes help to protect skin cells from the sun's ultraviolet radiation, according to a study by researchers from the University of Barcelona and the CSIC (Spanish National Research Council). The study supports the use of grapes or grape derivatives in sun protection products. Ultraviolet (UV) rays emitted by the sun are the leading environmental cause of skin complaints, causing skin cancer, sunburn and solar erythema, as well as premature ageing of the dermis and epidermis. Now, a Spanish study has proven that some substances in grapes can reduce ...

JRC develops new testing methods for contaminated sports drinks from Taiwan

2011-08-01

Brussels, 29 July 2011 - The European Commission's Joint Research Centre has developed three new methods to detect an illegal clouding agent which can be found in sports drinks imported from Taiwan. In late May, the Taiwanese authorities informed the European Commission that significant amounts of phthalates were illegally added to certain categories of sports drinks. These chemicals are believed to affect reproductive performance and fertility, and have been linked to developmental problems with children. Under a request from the Commission's Directorate-General for ...

FDA should invest in developing a new regulatory framework to replace flawed 510(k) medical device clearance process

2011-08-01

WASHINGTON — The U.S. Food and Drug Administration should gather the information needed to develop a new regulatory framework to replace the 35-year-old 510(k) clearance process for medical devices, says a new report from the Institute of Medicine. The 510(k) process lacks the legal basis to be a reliable premarket screen of the safety and effectiveness of moderate-risk Class II devices and cannot be transformed into one, concluded the committee that wrote the report. FDA's finite resources would be better invested in developing a new framework that uses both premarket ...

Survey: Ontarians expect better access to trauma centers for serious injuries

2011-08-01

TORONTO, Ont., July 29, 2011—More than eight in 10 Ontarians say they would want to be taken directly to a trauma centre if they were seriously injured, even if another hospital were closer, a new poll has found. The poll, conducted for researchers at St. Michael's Hospital, also found that 40 per cent of respondents believe they can get access to a trauma centre within an hour of calling 911. Neither event is guaranteed, said Dr. Avery Nathens, the hospital's trauma director. Nearly two-thirds (62 per cent) of seriously injured adults in Ontario are taken to their ...

Dissecting dyslexia: Linking reading to voice recognition

2011-08-01

When people recognize voices, part of what helps make voice recognition accurate is noticing how people pronounce words differently. But individuals with dyslexia don't experience this familiar language advantage, say researchers. The likely reason: "phonological impairment." Tyler Perrachione with the Massachusetts Institute of Technology explains, "Even though all people who speak a language use the same words, they say those words just a little bit differently from one another--what is called 'phonetics' in linguistics." Phonetics is concerned with the physical ...

Soybean genetic treasure trove found in Swedish village

2011-08-01

The first screening by U.S. Department of Agriculture (USDA) scientists of the American ancestors of soybeans for tolerance to ozone and other stresses had an eye-opening result: The world superstars of stress resistance hailed from a little village in far northern Sweden, called Fiskeby. The screeners, geneticist Tommy Carter and plant physiologist Kent Burkey, are with the Agricultural Research Service (ARS) in Raleigh, NC. Carter works in the ARS Soybean and Nitrogen Fixation Research Unit, and Burkey is in the agency's Plant Science Research Unit. ARS is USDA's principal ...

'Wonder material' graphene tapped for electronic memory devices

2011-08-01

Electronic memory devices, which store information, are increasingly expected to provide not only greater storage density, but also faster access to information. As storage density increases, however, power consumption and unwanted heat generation also increase, and the fidelity of accessing the memory is frequently diminished. Various platforms exist to overcome these hurdles, according to a team led by University of California at Los Angeles researchers, which they describe in detail in the AIP's Applied Physics Letters. A spin-transfer-torque device, for example, relies ...

Solar cells get a boost from bouncing light

2011-08-01

By engineering alternating layers of nanometer and micrometer particles, a team of engineers from the University of Minnesota has improved the efficiency of a type of solar cell by as much as 26 percent. These cells, known as dye-sensitized solar cells (DSSC), are made of titanium dioxide (TiO2), a photosensitive material that is less expensive than the more traditional silicon solar cells, which are rapidly approaching the theoretical limit of their efficiency. Current DSSC designs, however, are only about 10 percent efficient. One reason for this low efficiency is that ...

Motorcycle helmets hard on hearing

2011-08-01

The distinctive roar of a Harley's engine is loud, but studies have revealed the biggest source of noise for motorcyclists is actually generated by air whooshing over the riders' helmets. Even at legal speeds, the sound can exceed safe levels. Now, scientists have identified a key source of the rushing din. Researchers from the University of Bath and Bath Spa University placed motorcycles helmets atop mannequin heads, mounted them in a wind tunnel, and turned on the fans. By placing microphones at different locations around the helmet and at the mannequin's ear, the researchers ...

Warmed-up organic memory transistor has larger memory capacity

2011-08-01

Plastics are cheap, flexible, and relatively easy to manufacture, but they can also be more heat sensitive than other materials such as metals. The same goes for plastic (or organic) electronics, which offer the promise of foldable displays or thin, inexpensive devices, but react to temperature swings differently than traditional silicon-based electronics. So, researchers at the Hong Kong Polytechnic University decided to explore this temperature-dependent behavior more closely. They took a non-volatile organic memory transistor, made from the plastic pentacene and a layer ...

Best post-transplant drug regimen identified for patients with new kidneys

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: